About
Inner ear disease treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
626
By Phase
PHASE1/PHASE2: 1PHASE2: 3PHASE2/PHASE3: 1PHASE1: 1
By Status
COMPLETED: 5RECRUITING: 3
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT06370351Lead Sponsor
A Phase I/II Clinical Trial with SENS-501 in Children Suffering from Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations
PHASE1/PHASE2Recruiting
12 participants
Started: Jun 21, 2024 · Completed: Jul 31, 2031
NCT06354010Lead Sponsor
Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
N/ARecruiting
100 participants
Started: Jun 14, 2024 · Completed: Jul 31, 2027
NCT05628233Lead Sponsor
SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease
PHASE2Completed
48 participants
Started: Dec 30, 2022 · Completed: Jun 11, 2025
NCT05402813Lead Sponsor
Natural History in Children Up to 16 Years with Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes
N/ARecruiting
180 participants
Started: Nov 18, 2022 · Completed: Nov 18, 2028
NCT05258773Lead Sponsor
Evaluation of the Presence of SENS-401 in the Perilymph
PHASE2Completed
28 participants
Started: Aug 10, 2022 · Completed: May 31, 2024
Locations (1)
Headquarters
Montpellier, France
Map
Loading map...